Vertaling van "medicines for instance the belgian " (Nederlands → Frans) :

In this context the FAMHP supports provision of pharmacotherapeutic information to care providers and has concluded partnerships with independent organisations providing objective information about medicines (for instance the Belgian Centre for Pharmacotherapeutic Information – BCFI-CBIP and Project Farmaka, not-for-profit organisations). This process needs to take into consideration the expectations of healthcare professionals in terms of information content on the one hand, and the ease of access and consultation of the data on the other.
In this context the FAMHP supports provision of pharmacotherapeutic information to care providers and has concluded partnerships with independent organisations providing objective information about medicines (for instance the Belgian Centre for Pharmacotherapeutic Information – BCFI-CBIP and Project Farmaka, not-for-profit organisations). This process needs to take into consideration the expectations of healthcare professionals in terms of information content on the one hand, and the ease of access and consultation of the data on the other.

BAPCOC (with FPS Public Health) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Interdepartmental network on “information society services” (with FPS Economy) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI) Working group on blood of the Belgian Federal Supreme Health Council Working group on cells, tissues and organs of the Belgian Federal Supreme Health Council
BAPCOC (with FPS Public Health) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Interdepartmental network on “information society services” (with FPS Economy) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI) Working group on blood of the Belgian Federal Supreme Health Council Working group on cells, tissues and organs of the Belgian Federal Supreme Health Council

Stakeholders: Jean Alexiou (RBSR), Xavier Berteele (BBOT), Charlotte De Jonckheere (Federatie van Belgische Podologen), Benjamin Kerzmann (Belgian Society of Emergency and Disaster Medicine- BeSEDIM), Luc Lefebvre (Société Scientifique de Médecine Générale-SSMG), Pierre Maldague (Belgian Foot and Ankle Society-BFAS), Yves Maule (Association Francophone des Infirmier(e)s d'Urgence - AFIU), Lambert Stamatakis (Cabinet Ministre Des Affaires Sociales et Santé Publique), Peter Vaes (Axxon), Pieter Van Dyck (Royal belgian society of radiology - RBSR), Gert Verleyen (Vlaamse Vereniging Verpleegkundigen Spoedgevallenzorg-VVVS), Stefan Waegeneers (RIZIV - INAMI), Thierry Van Meerhaeghe (Association belge des podologues)
Stakeholders : Jean Alexiou (RBSR), Xavier Berteele (BBOT), Charlotte De Jonckheere (Federatie van Belgische Podologen), Benjamin Kerzmann (Belgian Society of Emergency and Disaster Medicine - BeSEDIM), Luc Lefebvre (Société Scientifique de Médecine Générale - SSMG), Pierre Maldague (Belgian Foot and Ankle Society - BFAS), Yves Maule (Association Francophone des Infirmier(e)s d'Urgence - AFIU), Lambert Stamatakis (Cabinet Ministre Des Affaires Sociales et Santé Publique), Peter Vaes (Axxon), Pieter Van Dyck (Royal belgian society of radiology - RBSR), Gert Verleyen (Vlaamse Vereniging Verpleegkundigen Spoedgevallenzorg - VVVS), Stefan Waegeneers (RIZIV - INAMI), Thierry Van Meerhaeghe (Association belge des podologues)

Alert System), regardless of their origin (Belgian, within or outside the European Union) ●● Dealing with the non-availability of essential medicines for Belgian patients ●● The secretariat of the advisory commission
Alert System), regardless of their origin (Belgian, within or outside the European Union) ●● Dealing with the non-availability of essential medicines for Belgian patients ●● The secretariat of the advisory commission

The latter has been designated as having expertise as an “Official Medicines Control Laboratory”, recognised by the FAMHP and the European Directorate for the Quality of Medicines (EDQM), for the monitoring of immunological products for veterinary use prior to marketing authorisation for the Belgian market.
The latter has been designated as having expertise as an “Official Medicines Control Laboratory”, recognised by the FAMHP and the European Directorate for the Quality of Medicines (EDQM), for the monitoring of immunological products for veterinary use prior to marketing authorisation for the Belgian market.

Homoeopathic medicines All homoeopathic medicines that are sold on the Belgian market are notified.
Homoeopathic medicines All homoeopathic medicines that are sold on the Belgian market are notified.

The Belgian Federal Agency for Medicines and Health Products, although it is still undergoing significant developments, will seize every opportunity to ensure higher levels of quality and improve its performance.
The Belgian Federal Agency for Medicines and Health Products, although it is still undergoing significant developments, will seize every opportunity to ensure higher levels of quality and improve its performance.

Externe validatoren: Jan Bosteels (Belgian Center for Evidence Based Medicine, CEBAM), Fabienne Liebens (ISALA, CHU Saint- Pierre, Bruxelles), Emiel Rutgers (The Netherlands Cancer Institute, NKI)
Validateurs externes Jan Bosteels (Belgian Center for Evidence Based Medicine, CEBAM), Fabienne Liebens (ISALA, CHU Saint- Pierre, Bruxelles), Emiel Rutgers (The Netherlands Cancer Institute, NKI)

f CEBAM = Belgian Centre for Evidence - Based Medicine
e CEBAM = Belgian Centre for Evidence - Based Medicine

The Belgian Federal Agency for Medicines and Health Products (FAMHP) was officially created on 1 January 2007.
The Belgian Federal Agency for Medicines and Health Products (FAMHP) was officially created on 1 January 2007.